封面
市場調查報告書
商品編碼
1066882

不孕檢驗的全球市場的展望、預測 (2022-2027年)

Fertility Test Market - Global Outlook & Forecast 2022-2027

出版日期: | 出版商: Arizton Advisory & Intelligence | 英文 271 Pages | 訂單完成後即時交付

價格

不孕檢驗的市場規模,在預測期間內預計以約7%的年複合成長率成長。對不孕檢驗的認識度提高,及治療的可及性提高是推動該市場成長的主要要素之一。

本報告提供全球不孕檢驗的市場調查,市場概要,市場成長的各種影響因素分析,主要趨勢,市場規模的變化、預測,各種區分、各主要國家的詳細分析,競爭環境,主要企業簡介等彙整資訊。

目錄

第1章 調查手法

第2章 調查目的

第3章 調查流程

第4章 調查範圍

第5章 前提條件、註記

第6章 市場概要

第7章 簡介

第8章 市場機會、市場趨勢

第9章 市場成長的促進因素

第10章 市場成長的阻礙因素

第11章 市場形勢

第12章 產品

  • 市場概要、成長引擎
  • 市場概要
  • 排卵檢測套組
    • 市場概要
    • 市場規模、預測
    • 地區
  • 妊娠監測器
    • 市場概要
    • 市場規模、預測
    • 地區
  • 精子試驗套件
    • 市場概要
    • 市場規模、預測
    • 地區

第13章 性別

  • 市場概要、成長引擎
  • 市場概要
  • 女性
    • 市場概要
    • 市場規模、預測
    • 地區
  • 男性
    • 市場概要
    • 市場規模、預測
    • 地區

第14章 流通管道

  • 市場概要、成長引擎
  • 市場概要
  • 線上銷售管道
    • 市場概要
    • 市場規模、預測
    • 地區
  • 零售藥局
    • 市場概要
    • 市場規模、預測
    • 地區
  • 醫院藥局
    • 市場概要
    • 市場規模、預測
    • 地區

第15章 終端用戶

  • 市場概要、成長引擎
  • 市場概要
  • 居家照護
    • 市場概要
    • 市場規模、預測
    • 地區
  • 專門&不孕診所
    • 市場概要
    • 市場規模、預測
    • 地區
  • 醫院
    • 市場概要
    • 市場規模、預測
    • 地區

第16章 地區

  • 市場概要、成長引擎
  • 地區概要
    • 全球女性的出生率下降

第17章 北美

第18章 歐洲

第19章 亞太地區

第20章 南美

第21章 中東、非洲

第22章 競爭情形

  • 競爭概要
  • 市場佔有率分析

第23章 企業簡介

  • AB ANALITICA
  • AVA AG
  • ADVACARE PHARMA
  • BABYSTART
  • BIOZHENA
  • CYCLOTEST
  • DNA DIAGNOSTICS CENTRE
  • EXSEED HEALTH
  • FERTILITY FOCUS
  • FEMOMETER
  • FAIRHAVEN HEALTH
  • GERATHERM MEDICAL AG
  • GIVE LEGACY
  • HILIN LIFE PRODUCTS
  • IXENSOR
  • LADY TECHNOLOGIES
  • LETSGETCHECKED
  • MEDICAL ELECTRONIC SYSTEM
  • MODERN FERTILITY
  • OOVA
  • PIRAMAL HEALTHCARE
  • PREMOM
  • QUANOVATE
  • RAIING MEDICAL
  • INITO (SAMPLYTICS TECHNOLOGIES)
  • SWIMCOUNT
  • SWISS PRECISION DIAGNOSTICS
  • TECO DIAGNOSTICS
  • YESMOM
  • VALLEY ELECTRONICS AG

第24章 報告摘要

  • 重要點
  • 策略性推薦事項

第25章 定量的摘要

第26章 附錄

Product Code: ARZ211234

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Fertility Test Market Report

The growing awareness about fertility test and greater access to treatment is one of the major factors driving the global fertility test market growth. Fertility test industry is growing at a healthy rate during the forecast period.

Over the past few years, the fertility test industry has been growing at a healthy rate on account of rising awareness regarding fertility testing, increasing maternal age of women in developed and developing regions, rapidly increasing infertility population across the globe, and awareness among the adult population.

According to Arizton's market research report the fertility test market by revenue is expected to grow at a CAGR of around 7% during the period 2022-2027.

MARKET SEGMENTATION

The Ovulation test kit segment dominate the market with high market share. Smart Phone based sperm analysis is an emerging trend in the global fertility test market. Use of AI in sprem analysis will boost the market growth

Based on distribution channels, the market is segmented into online sales channels, retail pharmacies, and hospitals pharmacies. In 2021, the online sales channel segment witnessed the highest market growth and is expected to grow at a CAGR of more than7% during the forecast period

Market Segmentation by Products

  • Ovulation Test Kits
  • Fertility Monitors
  • Sperm Test Kit

Market Segmentation by Gender

  • Male
  • Female

Market Segmentation by Distribution Channel

  • Online Sale Channels
  • Retail Pharmacies
  • Hospital Pharmacies

Market Segmentation by End-Users

  • Homecare
  • Speciality and Fertility Clinics
  • Hospitals

GEOGRAPHICAL ANALYSIS

Around 11% of North American women and 9% of men experience the fertility problem. Moreover, in the United States, 9% of men and 10% of women between the age group 15-44 years suffer from infertility problems which positively influence the market growth with driving demand for the fertility test.

Market Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East and Africa
    • Turkey
    • Saudi Arabia
    • South Africa

VENDOR ANALYSIS

The fertility test kit manufacturers are trying to achieve a high market share with different revenue generation strategies. Some of the sperm test kit manufacturing companies include swim count, advacare, DNA Diagnostics Centre, Hamilton Thorne, Home Health, Give Legacy.These companies deliver high-quality sperm test kits in domestic and international markets, and will achieve a higher share in the upcoming time in the fertility test market.

PROMINENT VENDORS

  • AB Analitica
  • Ava AG
  • Advacare Pharma
  • Babystart Ltd.
  • Biozhena
  • Cyclotest
  • DNA Diagnostics Center
  • Give Legacy Inc
  • Exseed Health
  • Lady Technologies
  • Fertility Focus limited
  • Femometer
  • Fairhaven Health
  • Geratherm Medical
  • Hilin Life Products Inc
  • iXensor
  • LetsGetChecked
  • Medical Electronic System
  • Modern Fertility
  • OOVA
  • Piramal Pharma
  • Premom
  • Raiing Medical
  • Samplytics Technologies
  • SwimCount
  • Swiss Precision Diagnostics
  • Teco Diagnostics
  • Yesmom
  • Valley Electronics AG

THE REPORT INCLUDES:

  • 1. The analysis of the global fertility test market provides market size and growth rate for the forecast period 2022-2027.
  • 2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the global fertility test market.
  • 3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
  • 4. It offers a complete overview of market segments and the regional outlook of the global fertility test market.
  • 5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
  • 4.1.1 INCLUSIONS
  • 4.1.2 EXCLUSIONS
  • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
  • 4.3.1 MARKET SEGMENTATION BY PRODUCT TYPE
  • 4.3.2 MARKET SEGMENTATION BY DISTRIBUTION CHANNELS
  • 4.3.3 MARKET SEGMENTATION BY END USER:
  • 4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

  • 7.1 OVERVIEW

8 MARKET OPPORTUNITIES & TRENDS

  • 8.1 TECHNOLOGICAL ADVANCES IN MALE FERTILITY TESTS
  • 8.2 SMARTPHONE-BASED SAMPLE ANALYSIS

9 MARKET GROWTH ENABLERS

  • 9.1 INCREASING MATERNAL AGE
  • 9.2 SURGE IN INFERTILITY RATES WORLDWIDE
  • 9.3 RISING AWARENESS OF FERTILITY TESTS

10 MARKET RESTRAINTS

  • 10.1 LACK OF ACCURACY IN AVAILABLE FERTILITY TESTS
  • 10.2 LOW AWARENESS & ACCEPTANCE OF FERTILITY TESTS

11 MARKET LANDSCAPE

  • 11.1 MARKET OVERVIEW
  • 11.2 MARKET SIZE & FORECAST
  • 11.2.1 MARKET SHARE BY GEOGRAPHY
  • 11.2.2 MARKET SHARE BY PRODUCTS
  • 11.2.3 MARKET SHARE BY GENDER
  • 11.2.4 MARKET SHARE BY DISTRIBUTION CHANNEL
  • 11.2.5 MARKET SHARE BY END USER
  • 11.3 FIVE FORCES ANALYSIS
  • 11.3.1 THREAT OF NEW ENTRANTS
  • 11.3.2 BARGAINING POWER OF SUPPLIERS
  • 11.3.3 BARGAINING POWER OF BUYERS
  • 11.3.4 THREAT OF SUBSTITUTES
  • 11.3.5 COMPETITIVE RIVALRY

12 PRODUCTS

  • 12.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 12.2 MARKET OVERVIEW
  • 12.3 OVULATION TEST KITS
  • 12.3.1 MARKET OVERVIEW
  • 12.3.2 MARKET SIZE & FORECAST
  • 12.3.3 MARKET BY GEOGRAPHY
  • 12.4 FERTILITY MONITORS
  • 12.4.1 MARKET OVERVIEW
  • 12.4.2 MARKET SIZE & FORECAST
  • 12.4.3 MARKET BY GEOGRAPHY
  • 12.5 SPERM TEST KITS
  • 12.5.1 MARKET OVERVIEW
  • 12.5.2 MARKET SIZE & FORECAST
  • 12.5.3 MARKET BY GEOGRAPHY

13 GENDER

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 FEMALE
  • 13.3.1 MARKET OVERVIEW
  • 13.3.2 MARKET SIZE & FORECAST
  • 13.3.3 MARKET BY GEOGRAPHY
  • 13.4 MALE
  • 13.4.1 MARKET OVERVIEW
  • 13.4.2 MARKET SIZE & FORECAST
  • 13.4.3 MARKET BY GEOGRAPHY

14 DISTRIBUTION CHANNELS

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 ONLINE SALE CHANNELS
  • 14.3.1 MARKET OVERVIEW
  • 14.3.2 MARKET SIZE & FORECAST
  • 14.3.3 MARKET BY GEOGRAPHY
  • 14.4 RETAIL PHARMACIES
  • 14.4.1 MARKET OVERVIEW
  • 14.4.2 MARKET SIZE & FORECAST
  • 14.4.3 MARKET BY GEOGRAPHY
  • 14.5 HOSPITAL PHARMACIES
  • 14.5.1 MARKET OVERVIEW
  • 14.5.2 MARKET SIZE & FORECAST
  • 14.5.3 MARKET BY GEOGRAPHY

15 END USERS

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 MARKET OVERVIEW
  • 15.3 HOMECARE
  • 15.3.1 MARKET OVERVIEW
  • 15.3.2 MARKET SIZE & FORECAST
  • 15.3.3 MARKET BY GEOGRAPHY
  • 15.4 SPECIALTY & FERILITY CLINICS
  • 15.4.1 MARKET OVERVIEW
  • 15.4.2 MARKET SIZE & FORECAST
  • 15.4.3 MARKET BY GEOGRAPHY
  • 15.5 HOSPITALS
  • 15.5.1 MARKET OVERVIEW
  • 15.5.2 MARKET SIZE & FORECAST
  • 15.5.3 MARKET BY GEOGRAPHY

16 GEOGRAPHY

  • 16.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 16.2 GEOGRAPHIC OVERVIEW
  • 16.2.1 DECLINE IN GLOBAL FEMALE FERTILITY RATE (REDUCTION PER WOMAN)

17 NORTH AMERICA

  • 17.1 MARKET OVERVIEW
  • 17.2 MARKET SIZE & FORECAST
  • 17.3 KEY COUNTRIES
  • 17.3.1 US: MARKET SIZE & FORECAST
  • 17.3.2 CANADA: MARKET SIZE & FORECAST
  • 17.4 PRODUCTS
  • 17.5 GENDER
  • 17.6 DISTRIBUTION CHANNEL
  • 17.7 END USERS

18 EUROPE

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
  • 18.3 KEY COUNTRIES
  • 18.3.1 GERMANY: MARKET SIZE & FORECAST
  • 18.3.2 FRANCE: MARKET SIZE & FORECAST
  • 18.3.3 UK: MARKET SIZE & FORECAST
  • 18.3.4 ITALY: MARKET SIZE & FORECAST
  • 18.3.5 SPAIN: MARKET SIZE & FORECAST
  • 18.4 PRODUCTS
  • 18.5 GENDER
  • 18.6 DISTRIBUTION CHANNEL
  • 18.7 END USER

19 APAC

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
  • 19.3 KEY COUNTRIES
  • 19.3.1 CHINA: MARKET SIZE & FORECAST
  • 19.3.2 JAPAN: MARKET SIZE & FORECAST
  • 19.3.3 INDIA: MARKET SIZE & FORECAST
  • 19.3.4 AUSTRALIA: MARKET SIZE & FORECAST
  • 19.3.5 SOUTH KOREA: MARKET SIZE & FORECAST
  • 19.4 PRODUCTS
  • 19.5 GENDER
  • 19.6 DISTRIBUTION CHANNEL
  • 19.7 END USER

20 LATIN AMERICA

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
  • 20.3 KEY COUNTRIES
  • 20.3.1 BRAZIL: MARKET SIZE & FORECAST
  • 20.3.2 MEXICO: MARKET SIZE & FORECAST
  • 20.3.3 ARGENTINA: MARKET SIZE & FORECAST
  • 20.4 PRODUCTS
  • 20.5 GENDER
  • 20.6 DISTRIBUTION CHANNEL
  • 20.7 END USER

21 MIDDLE EAST & AFRICA

  • 21.1 MARKET OVERVIEW
  • 21.2 MARKET SIZE & FORECAST
  • 21.3 KEY COUNTRIES
  • 21.3.1 TURKEY: MARKET SIZE & FORECAST
  • 21.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
  • 21.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST
  • 21.4 PRODUCTS
  • 21.5 GENDER
  • 21.6 DISTRIBUTION CHANNEL
  • 21.7 END USER

22 COMPETITIVE LANDSCAPE

  • 22.1 COMPETITION OVERVIEW
  • 22.2 MARKET SHARE ANALYSIS

23 COMPANY PROFILES

  • 23.1 AB ANALITICA
  • 23.1.1 BUSINESS OVERVIEW
  • 23.1.2 PRODUCT OFFERINGS
  • 23.2 AVA AG
  • 23.2.1 BUSINESS OVERVIEW
  • 23.2.2 PRODUCT OFFERINGS
  • 23.3 ADVACARE PHARMA
  • 23.3.1 BUSINESS OVERVIEW
  • 23.3.2 PRODUCT OFFERINGS
  • 23.4 BABYSTART
  • 23.4.1 BUSINESS OVERVIEW
  • 23.4.2 PRODUCT OFFERINGS
  • 23.5 BIOZHENA
  • 23.5.1 BUSINESS OVERVIEW
  • 23.5.2 PRODUCT OFFERINGS
  • 23.6 CYCLOTEST
  • 23.6.1 BUSINESS OVERVIEW
  • 23.6.2 PRODUCT OFFERINGS
  • 23.7 DNA DIAGNOSTICS CENTRE
  • 23.7.1 BUSINESS OVERVIEW
  • 23.7.2 PRODUCT OFFERINGS
  • 23.8 EXSEED HEALTH
  • 23.8.1 BUSINESS OVERVIEW
  • 23.8.2 PRODUCT OFFERINGS
  • 23.9 FERTILITY FOCUS
  • 23.9.1 BUSINESS OVERVIEW
  • 23.9.2 PRODUCT OFFERINGS
  • 23.10 FEMOMETER
  • 23.10.1 BUSINESS OVERVIEW
  • 23.10.2 PRODUCT OFFERINGS
  • 23.11 FAIRHAVEN HEALTH
  • 23.11.1 BUSINESS OVERVIEW
  • 23.11.2 PRODUCT OFFERINGS
  • 23.12 GERATHERM MEDICAL AG
  • 23.12.1 BUSINESS OVERVIEW
  • 23.12.2 PRODUCT OFFERINGS
  • 23.13 GIVE LEGACY
  • 23.13.1 BUSINESS OVERVIEW
  • 23.13.2 PRODUCT OFFERINGS
  • 23.14 HILIN LIFE PRODUCTS
  • 23.14.1 BUSINESS OVERVIEW
  • 23.14.2 PRODUCT OFFERINGS
  • 23.15 IXENSOR
  • 23.15.1 BUSINESS OVERVIEW
  • 23.15.2 PRODUCT OFFERINGS
  • 23.16 LADY TECHNOLOGIES
  • 23.16.1 BUSINESS OVERVIEW
  • 23.16.2 PRODUCT OFFERINGS
  • 23.17 LETSGETCHECKED
  • 23.17.1 BUSINESS OVERVIEW
  • 23.17.2 PRODUCT OFFERINGS
  • 23.18 MEDICAL ELECTRONIC SYSTEM
  • 23.18.1 BUSINESS OVERVIEW
  • 23.18.2 PRODUCT OFFERINGS
  • 23.19 MODERN FERTILITY
  • 23.19.1 BUSINESS OVERVIEW
  • 23.19.2 PRODUCT OFFERINGS
  • 23.20 OOVA
  • 23.20.1 BUSINESS OVERVIEW
  • 23.20.2 PRODUCT OFFERINGS
  • 23.21 PIRAMAL HEALTHCARE
  • 23.21.1 BUSINESS OVERVIEW
  • 23.21.2 PRODUCT OFFERINGS
  • 23.22 PREMOM
  • 23.22.1 BUSINESS OVERVIEW
  • 23.22.2 PRODUCT OFFERINGS
  • 23.23 QUANOVATE
  • 23.23.1 BUSINESS OVERVIEW
  • 23.24 RAIING MEDICAL
  • 23.24.1 BUSINESS OVERVIEW
  • 23.24.2 PRODUCT OFFERINGS
  • 23.25 INITO (SAMPLYTICS TECHNOLOGIES)
  • 23.25.1 BUSINESS OVERVIEW
  • 23.25.2 PRODUCT OFFERINGS
  • 23.26 SWIMCOUNT
  • 23.26.1 BUSINESS OVERVIEW
  • 23.26.2 PRODUCT OFFERINGS
  • 23.27 SWISS PRECISION DIAGNOSTICS
  • 23.27.1 BUSINESS OVERVIEW
  • 23.27.2 PRODUCT OFFERINGS
  • 23.28 TECO DIAGNOSTICS
  • 23.28.1 BUSINESS OVERVIEW
  • 23.28.2 PRODUCT OFFERINGS
  • 23.29 YESMOM
  • 23.29.1 BUSINESS OVERVIEW
  • 23.29.2 PRODUCT OFFERINGS
  • 23.30 VALLEY ELECTRONICS AG
  • 23.30.1 BUSINESS OVERVIEW
  • 23.30.2 PRODUCT OFFERINGS

24 REPORT SUMMARY

  • 24.1 KEY TAKEAWAYS
  • 24.2 STRATEGIC RECOMMENDATIONS

25 QUANTITATIVE SUMMARY

  • 25.1 MARKET BY GEOGRAPHY
  • 25.1.1 GLOBAL FERTILITY TEST MARKET BY GEOGRAPHY
  • 25.2 MARKET BY PRODUCTS
  • 25.2.1 NORTH AMERICA: FERTILITY TEST MARKET BY PRODUCTS
  • 25.2.2 EUROPE: FERTILITY TEST MARKET BY PRODUCT
  • 25.2.3 APAC: FERTILITY TEST MARKET BY PRODUCTS
  • 25.2.4 LATIN AMERICA: FERTILITY TEST MARKET BY PRODUCTS
  • 25.2.5 MIDDLE EAST & AFRICA: FERTILITY TEST MARKET BY PRODUCTS
  • 25.3 MARKET BY GENDER
  • 25.3.1 NORTH AMERICA: FERTILITY TEST MARKET BY GENDER
  • 25.3.2 EUROPE: FERTILITY TEST MARKET BY GENDER
  • 25.3.3 APAC: FERTILITY TEST MARKET BY GENDER
  • 25.3.4 LATIN AMERICA: FERTILITY TEST MARKET BY GENDER
  • 25.3.5 MIDDLE EAST & AFRICA: FERTILITY TEST MARKET BY GENDER
  • 25.4 MARKET BY DISTRIBUTION CHANNEL
  • 25.4.1 NORTH AMERICA: MARKET BY DISTRIBUTION CHANNELS
  • 25.4.2 EUROPE: MARKET BY DSTRIBUTION CHANNELS
  • 25.4.3 APAC: MARKET BY DISTRIBUTION CHANNELS
  • 25.4.4 LATIN AMERICA: MARKET BY DSTRIBUTION CHANNELS
  • 25.4.5 MIDDLE EAST & AFRICA: MARKET BY DSTRIBUTION CHANNELS
  • 25.5 MARKET BY END USER
  • 25.5.1 NORTH AMERICA: MARKET BY END USER
  • 25.5.2 EUROPE: MARKET BY END USER
  • 25.5.3 APAC: MARKET BY END USER
  • 25.5.4 LATINAMERICA: MARKET BY END USER
  • 25.5.5 MIDDLE EAST & AFRICA: MARKET BY END USER
  • 25.6 MARKET BY GEOGRAPHY
  • 25.6.1 OVULATION TEST KIT MARKET BY GEOGRAPHY
  • 25.6.2 FERTILITY MONITORS MARKET BY GEOGRAPHY
  • 25.6.3 SPERM TEST KIT MARKET BY GEOGRAPHY
  • 25.6.4 FEMALE: MARKET BY GEOGRAPHY
  • 25.6.5 MALE: MARKET BY GEOGRAPHY
  • 25.6.6 ONLINE SALES CHANNELS: MARKET BY GEOGRAPHY
  • 25.6.7 RETAIL PHARMACIES: MARKET BY GEOGRAPHY
  • 25.6.8 HOSPITAL PHARMACIES: MARKET BY GEOGRAPHY
  • 25.6.9 HOMECARE: MARKET BY GEOGRAPHY
  • 25.6.10 SPECIALTY & FERTILITY CLINICS: MARKET BY GEOGRAPHY
  • 25.6.11 HOSPITAL: MARKET BY GEOGRAPHY

26 APPENDIX

  • 26.1 ABBREVIATIONS

LIST OF EXHIBITS

EXHIBIT 1 SEGMENTATION OF GLOBAL FERTILITY TEST MARKET

EXHIBIT 2 GLOBAL FERTILITY TEST MARKET SIZE CALCULATION APPROACH 2021

EXHIBIT 3 GLOBAL BIRTH RATE PER WOMAN & ANNUAL % CHANGE 2000-2021

EXHIBIT 4 IMPACT OF TECHNOLOGICAL ADVANCES IN MALE FERTILITY TESTS

EXHIBIT 5 IMPACT OF SMARTPHONE-BASED SAMPLE ANALYSIS

EXHIBIT 6 IMPACT OF INCREASING MATERNAL AGE

EXHIBIT 7 GLOBAL FEMALE LITERACY RATE 2015-2020 (%)

EXHIBIT 8 GLOBAL MATERNAL AGE RANGE 2011-2014 (%)

EXHIBIT 9 IMPACT OF SURGE IN INFERTILITY RATES WORLDWIDE

EXHIBIT 10 CAUSES & STATISTICS FOR INFERTILITY WORLDWIDE

EXHIBIT 11 CAUSES OF FEMALE INFERTILITY

EXHIBIT 12 IMPACT OF RISING AWARENESS OF FERTILITY TESTS

EXHIBIT 13 IMPACT OF LACK OF ACCURACY IN AVAILABLE FERTILITY TESTS

EXHIBIT 14 IMPACT OF LOW AWARENESS & ACCEPTANCE OF FERTILITY TESTS

EXHIBIT 15 GLOBAL FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 16 GLOBAL FERTILITY TEST MARKET BY GEOGRAPHY

EXHIBIT 17 GLOBAL FERTILITY TEST MARKET BY PRODUCTS

EXHIBIT 18 GLOBAL FERTILITY TEST MARKET BY GENDER

EXHIBIT 19 GLOBAL FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL

EXHIBIT 20 GLOBAL FERTILITY TEST MARKET BY END USER

EXHIBIT 21 FIVE FORCES ANALYSIS 2021

EXHIBIT 22 INCREMENTAL GROWTH BY PRODUCTS 2021 & 2027

EXHIBIT 23 GLOBAL FERTILITY TEST MARKET BY PRODUCTS 2021-2027

EXHIBIT 24 GLOBAL FERTILITY TEST MARKET BY PRODUCT: INCREMENTAL GROWTH

EXHIBIT 25 GLOBAL FERTILITY TEST MARKET BY PRODUCT: ABSOLUTE GROWTH

EXHIBIT 26 MAJOR VENDORS SELLING OVULATION TEST KITS 2021

EXHIBIT 27 GLOBAL FERTILITY TEST MARKET BY OVULATION TEST KITS: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 28 ADVANTAGES OF OVULATION TEST KITS

EXHIBIT 29 GLOBAL FERTILITY TEST MARKET BY OVULATION TEST KITS 2021-2027 ($ MILLION)

EXHIBIT 30 BEST-SELLING FERTILITY MONITOR KITS 2021

EXHIBIT 31 GLOBAL FERTILITY TEST MARKET BY FERTILITY MONITORS: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 32 GLOBAL FERTILITY TEST MARKET BY FERTILITY MONITORS 2021-2027 ($ MILLION)

EXHIBIT 33 CAUSES OF MALE INFERTILITY

EXHIBIT 34 MALE INFERTILITY RATE BY REGIONS

EXHIBIT 35 GLOBAL FERTILITY TEST MARKET BY SPERM TEST KITS: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 36 GLOBAL FERTILITY TEST MARKET BY SPERM TEST KITS 2021-2027 ($ MILLION)

EXHIBIT 37 INCREMENTAL GROWTH BY GENDER 2021 & 2027

EXHIBIT 38 GLOBAL FERTILITY TEST MARKET BY GENDER 2021-2027

EXHIBIT 39 GLOBAL FERTILITY TEST MARKET BY GENDER: INCREMENTAL GROWTH

EXHIBIT 40 GLOBAL FERTILITY TEST MARKET BY GENDER: ABSOLUTE GROWTH

EXHIBIT 41 DECLINE IN FEMALE FERTILITY RATE BY REGION 1990-2019 (%)

EXHIBIT 42 FEMALE INFERTILITY RATE BY MATERNAL AGE GROUP (%)

EXHIBIT 43 GLOBAL FEMALE FERTILITY TEST MARKET: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 44 GLOBAL FEMALE FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 45 GLOBAL MALE FERTILITY TEST MARKET: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 46 GLOBAL MALE FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 47 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 48 GLOBAL FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL 2021-2027

EXHIBIT 49 GLOBAL FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL: INCREMENTAL GROWTH

EXHIBIT 50 GLOBAL FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL: ABSOLUTE GROWTH

EXHIBIT 51 GLOBAL FERTILITY TEST MARKET BY ONLINE SALES CHANNELS: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 52 GLOBAL FERTILITY TEST MARKET BY ONLINE SALES CHANNELS 2021-2027 ($ MILLION)

EXHIBIT 53 GLOBAL FERTILITY TEST MARKET BY RETAIL PHARMACIES: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 54 GLOBAL FERTILITY TEST MARKET BY RETAIL PHARMACIES 2021-2027 ($ MILLION)

EXHIBIT 55 GLOBAL FERTILITY TEST MARKET BY HOSPITAL PHARMACIES: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 56 GLOBAL FERTILITY TEST MARKET BY HOSPITAL PHARMACIES 2021-2027 ($ MILLION)

EXHIBIT 57 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 58 GLOBAL FERTILITY TEST MARKET BY END USER 2021-2027

EXHIBIT 59 GLOBAL FERTILITY TEST MARKET BY END USER: INCREMENTAL GROWTH

EXHIBIT 60 TRENDS IN HOMECARE FERTILITY TEST PRODUCTS

EXHIBIT 61 GLOBAL FERTILITY TEST MARKET BY HOMECARE: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 62 GLOBAL FERTILITY TEST MARKET BY HOMECARE 2021-2027 ($ MILLION)

EXHIBIT 63 GLOBAL FERTILITY TEST MARKET BY SPECIALTY & FERTILITY CLINICS: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 64 GLOBAL FERTILITY TEST MARKET BY SPECIALTY & FERTILITY CLINICS 2021-2027 ($ MILLION)

EXHIBIT 65 GLOBAL FERTILITY TEST MARKET BY HOSPITALS: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 66 GLOBAL FERTILITY TEST MARKET BY HOSPITALS 2021-2027 ($ MILLION)

EXHIBIT 67 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 68 GLOBAL FERTILITY RATE 2021

EXHIBIT 69 GLOBAL FERTILITY TEST MARKET BY GEOGRAPHY: INCREMENTAL GROWTH

EXHIBIT 70 GLOBAL FERTILITY TEST MARKET BY GEOGRAPHY: ABSOLUTE GROWTH

EXHIBIT 71 GROWTH DRIVERS FOR NORTH AMERICA FERTILITY TEST MARKET

EXHIBIT 72 NORTH AMERICA FERTILITY TEST MARKET: KEY COUNTRIES (2020)

EXHIBIT 73 POPULATION AFFECTED BY INFERTILITY IN NORTH AMERICA 1984, 1992, & 2019 (%)

EXHIBIT 74 NORTH AMERICA FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 75 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027

EXHIBIT 76 US BIRTH RATE BY MATERNAL AGE (PER 1,000 WOMEN)

EXHIBIT 77 FERTILITY & PREGNANCY RELATED SUGGESTIONS BY DOCTORS IN US (%)

EXHIBIT 78 US FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 79 GROWTH DRIVERS FOR FERTILITY TESTS IN CANADA

EXHIBIT 80 AVERAGE FEMALE AGE DURING FIRST BIRTH IN CANADA (2012-2016)

EXHIBIT 81 FERTILITY RATE BY AGE GROUP IN CANADA 2016 (PER THOUSAND WOMEN)

EXHIBIT 82 CANADA FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 83 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 84 INCREMENTAL GROWTH BY GENDER 2021 & 2027

EXHIBIT 85 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 86 INCREMENTAL GROWTH BY END USERS 2021 & 2027

EXHIBIT 87 FERTILITY RATE BY MATERNAL AGE GROUP IN EUROPE 2001, 2010, & 2019

EXHIBIT 88 KEY COUNTRIES IN EUROPE FERTILITY TEST MARKET 2020

EXHIBIT 89 EUROPE FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 90 INCREMENTAL GROWTH IN EUROPE 2021 & 2027

EXHIBIT 91 BIRTH RATE PER YEAR IN GERMANY 2016-2020

EXHIBIT 92 FERTILITY RATE IN GERMANY 2016-2020

EXHIBIT 93 GERMANY FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 94 FRANCE FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 95 YEAR-ON-YEAR FERTILITY RATE IN ENGLAND & WALES 2011-2019

EXHIBIT 96 FERTILITY RATE IN UK BY AGE GROUP (LIVE BIRTHS PER 1000 WOMEN)

EXHIBIT 97 UK FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 98 ITALY FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 99 PREVALENCE OF INFERTILITY IN SPAIN

EXHIBIT 100 SPAIN FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 101 INCREMENTAL GROWTH BY PRODUCTS 2021 & 2027

EXHIBIT 102 INCREMENTAL GROWTH BY GENDER 2021 & 2027

EXHIBIT 103 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 104 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 105 GROWTH DRIVERS FOR APAC FERTILITY TEST MARKET (BY COUNTRIES)

EXHIBIT 106 APAC FERTILITY TEST MARKET: KEY COUNTRIES (2020)

EXHIBIT 107 APAC FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 108 INCREMENTAL GROWTH IN APAC 2021 & 2027

EXHIBIT 109 INFERTILITY STATISTICS IN CHINA

EXHIBIT 110 CHINA FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 111 PROPORTION OF SUB-FERTILE JAPANESE COUPLES SEEKING FERTILITY TREATMENT BASED ON HOUSEHOLD INCOME (%)

EXHIBIT 112 JAPAN FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 113 FEMALE FERTILITY RATE IN INDIA (PER WOMAN) 2011-2021

EXHIBIT 114 INDIA FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 115 CAUSES FOR INFERTILITY AMONG AUSTRALIAN COUPLES

EXHIBIT 116 AUSTRALIA FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 117 DECLINE IN FERTILITY RATE ACROSS SOUTH KOREA 2013-2020

EXHIBIT 118 SOUTH KOREA FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 119 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 120 INCREMENTAL GROWTH BY GENDER 2021 & 2027

EXHIBIT 121 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 122 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 123 LATIN AMERICA FERTILITY TEST MARKET: KEY COUNTRIES 2020

EXHIBIT 124 LATIN AMERICA FERTILITY TEST MARKET2021-2027 ($ MILLION)

EXHIBIT 125 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027

EXHIBIT 126 FEMALE FERTILITY RATE IN BRAZIL 2017-2021

EXHIBIT 127 BIRTH RATE IN BRAZIL (PER WOMAN) 2005-2019

EXHIBIT 128 BRAZIL FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 129 BIRTH RATE IN MEXICO (PER WOMAN) 2009-2019

EXHIBIT 130 BIRTH RATE IN MEXICO (PER 1,000 WOMEN)

EXHIBIT 131 MEXICO FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 132 ARGENTINA FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 133 INCREMENTAL GROWTH BY PRODUCTS 2021 & 2027

EXHIBIT 134 INCREMENTAL GROWTH BY GENDER 2021 & 2027

EXHIBIT 135 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 136 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 137 MIDDLE EAST AFRICA FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 138 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027

EXHIBIT 139 TURKEY FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 140 FACTORS CAUSING INFERTILITY AMONG 31-40 FEMALE AGE GROUP IN SAUDI ARABIA

EXHIBIT 141 SAUDI ARABIA FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 142 SOUTH AFRICA FERTILITY TEST MARKET 2021-2027 ($ MILLION)

EXHIBIT 143 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 144 INCREMENTAL GROWTH BY GENDER 2021 & 2027

EXHIBIT 145 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 146 INCREMENTAL GROWTH BY END USER 2021 & 2027

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015-2021

TABLE 3 GLOBAL FERTILITY TEST MARKET BY OVULATION TEST KITS 2021-2027 ($ MILLION)

TABLE 4 GLOBAL FERTILITY TEST MARKET BY FERTILITY MONITORS 2021-2027 ($ MILLION)

TABLE 5 GLOBAL FERTILITY TEST MARKET BY SPERM TEST KITS 2021-2027 ($ MILLION)

TABLE 6 GLOBAL FEMALE FERTILITY TEST MARKET 2021-2027 ($ MILLION)

TABLE 7 GLOBAL MALE FERTILITY TEST MARKET 2021-2027 ($ MILLION)

TABLE 8 GLOBAL FERTILITY TEST MARKET BY ONLINE SALES CHANNEL 2021-2027 ($ MILLION)

TABLE 9 GLOBAL FERTILITY TEST MARKET BY RETAIL PHARMACIES 2021-2027 ($ MILLION)

TABLE 10 GLOBAL FERTILITY TEST MARKET BY HOSPITAL PHARMACIES 2021-2027 ($ MILLION)

TABLE 11 GLOBAL FERTILITY TEST MARKET BY HOMECARE 2021-2027 ($ MILLION)

TABLE 12 GLOBAL FERTILITY TEST MARKET BY SPECIALTY & FERTILITY CLINICS 2021-2027 ($ MILLION)

TABLE 13 GLOBAL FERTILITY TEST MARKET BY HOSPITALS 2021-2027 ($ MILLION) (GEOGRAPHY)

TABLE 14 AB ANALITICA: MAJOR PRODUCT OFFERINGS

TABLE 15 AVA AG: MAJOR PRODUCT OFFERINGS

TABLE 16 ADVACARE PHARMA: MAJOR PRODUCT OFFERINGS

TABLE 17 BABYSTART: MAJOR PRODUCT OFFERINGS

TABLE 18 BIOZHENA: MAJOR PRODUCT OFFERINGS

TABLE 19 CYCLOTEST: MAJOR PRODUCT OFFERINGS

TABLE 20 DNA DIAGNOSTICS CENTER: MAJOR PRODUCT OFFERINGS

TABLE 21 EXSEED HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 22 FERTILITY FOCUS: MAJOR PRODUCT OFFERINGS

TABLE 23 FEMOMETER: MAJOR PRODUCT OFFERINGS

TABLE 24 FAIRHAVEN HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 25 GERATHERM MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 26 GIVE LEGACY: MAJOR PRODUCT OFFERINGS

TABLE 27 HILIN LIFE PRODUCTS: MAJOR PRODUCT OFFERINGS

TABLE 28 IXENSOR: MAJOR PRODUCT OFFERINGS

TABLE 29 LADY TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 30 LETSGETCHECKED: MAJOR PRODUCT OFFERINGS

TABLE 31 MEDICAL ELECTRONIC SYSTEM: MAJOR PRODUCT OFFERINGS

TABLE 32 MODERN FERTILITY: MAJOR PRODUCT OFFERINGS

TABLE 33 OOVA: MAJOR PRODUCT OFFERINGS

TABLE 34 PIRAMAL PHARMA: MAJOR PRODUCT OFFERINGS

TABLE 35 PREMOM: MAJOR PRODUCT OFFERINGS

TABLE 36 QUANOVATE: MAJOR PRODUCT OFFERINGS

TABLE 37 RAIING MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 38 SAMPLYTICS TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 39 SWIMCOUNT: MAJOR PRODUCT OFFERINGS

TABLE 40 SWISS PRECISION DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 41 TECO DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 42 YESMOM: MAJOR PRODUCT OFFERINGS

TABLE 43 VALLEY ELECTRONICS AG: MAJOR PRODUCT OFFERINGS

TABLE 44 GLOBAL FERTILITY TEST MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)

TABLE 45 NORTH AMERICA FERTILITY TEST MARKET BY PRODUCT 2021-2027 ($ MILLION)

TABLE 46 EUROPE FERTILITY TEST MARKET BY PRODUCT 2021-2027 ($ MILLION)

TABLE 47 APAC FERTILITY TEST MARKET BY PRODUCT 2021-2027 ($ MILLION)

TABLE 48 LATIN AMERICA FERTILITY TEST MARKET BY PRODUCT 2021-2027 ($ MILLION)

TABLE 49 MIDDLE EAST & AFRICA FERTILITY TEST MARKET BY PRODUCT 2021-2027 ($ MILLION)

TABLE 50 NORTH AMERICA FERTILITY TEST MARKET BY GENDER 2021-2027 ($ MILLION)

TABLE 51 EUROPE FERTILITY TEST MARKET BY GENDER 2021-2027 ($ MILLION)

TABLE 52 APAC FERTILITY TEST MARKET BY GENDER 2021-2027 ($ MILLION)

TABLE 53 LATIN AMERICA FERTILITY TEST MARKET BY GENDER 2021-2027 ($ MILLION)

TABLE 54 MIDDLE EAST & AFRICA FERTILITY TEST MARKET BY GENDER 2021-2027 ($ MILLION)

TABLE 55 NORTH AMERICA FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)

TABLE 56 EUROPE FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)

TABLE 57 APAC FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)

TABLE 58 LATIN AMERICA FERTILITY TEST MARKET BY DISTRIBUTION CHANNELS 2021-2027 ($ MILLION)

TABLE 59 MIDDLE EAST & AFRICA FERTILITY TEST MARKET BY DISTRIBUTION CHANNELS 2021-2027 ($ MILLION)

TABLE 60 NORTH AMERICA FERTILITY TEST MARKET BY END USER 2021-2027 ($ MILLION)

TABLE 61 EUROPE FERTILITY TEST MARKET BY END USER 2021-2027 ($ MILLION)

TABLE 62 APAC FERTILITY TEST MARKET BY END USER 2021-2027 ($ MILLION)

TABLE 63 LATIN AMERICA FERTILITY TEST MARKET BY END USER 2021-2027 ($ MILLION)

TABLE 64 MIDDLE EAST & AFRICA FERTILITY TEST MARKET BY END USER 2021-2027 ($ MILLION)

TABLE 65 GLOBAL FERTILITY TEST MARKET BY OVULATION TEST KIT 2021-2027 ($ MILLION)

TABLE 66 GLOBAL FERTILITY TEST MARKET BY FERTILITY MONITORS 2021-2027 ($ MILLION)

TABLE 67 GLOBAL FERTILITY TEST MARKET BY SPERM TEST KIT 2021-2027 ($ MILLION)

TABLE 68 GLOBAL FEMALE FERTILITY TEST MARKET 2021-2027 ($ MILLION)

TABLE 69 GLOBAL MALE FERTILITY TEST MARKET 2021-2027 ($ MILLION)

TABLE 70 GLOBAL FERTILITY TEST MARKET BY ONLINE SALES CHANNELS 2021-2027 ($ MILLION)

TABLE 71 GLOBAL FERTILITY TEST MARKET BY RETAIL PHARMACIES 2021-2027 ($ MILLION)

TABLE 72 GLOBAL FERTILITY TEST MARKET BY HOSPITAL PHARMACIES 2021-2027 ($ MILLION)

TABLE 73 GLOBAL FERTILITY TEST MARKET BY HOMECARE 2021-2027 ($ MILLION)

TABLE 74 GLOBAL FERTILITY TEST MARKET BY SPECIALTY & FERTILITY CLINICS 2021-2027 ($ MILLION)

TABLE 75 GLOBAL FERTILITY TEST MARKET BY HOSPITAL 2021-2027 ($ MILLION)